|9 Months Ended|
Sep. 30, 2021
13. Income Taxes
The Company recorded an income tax benefit of $1.5 million for the nine months ended September 30, 2020, as a result of the Coronavirus Aid, Relief, and Economic Security Act and no income tax provision for the nine months ended September 30, 2021. The Company continues to maintain a full valuation allowance against its remaining net deferred tax assets. During the nine months ended September 30, 2021 the Company received $1.5 million in cash for its income tax receivable.
The Company has a total of $5.9 million of gross unrecognized tax benefits, none of which would affect the effective tax rate upon realization as it currently has a full valuation allowance against its U.S. net deferred tax assets. The reversal of related deferred tax assets will be offset by a valuation allowance, should any of these uncertain tax positions be favorably settled in the future.
The Company does not expect its unrecognized tax benefits to change significantly over the next twelve months. The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Through September 30, 2021, the Company has not accrued interest or penalties related to uncertain tax positions.
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef